Original article
Fibrinogen and fibrinolytic variables in relation to anthropometry, lipids and blood pressure. The Northern Sweden Monica study

https://doi.org/10.1016/0895-4356(94)90298-4Get rights and content

Abstract

Fibrinolysis is dependent upon plasminogen activator (tPA) activity while high fibrinogen levels increase the risk of thromboembolic events. From a cross-sectional population sample of 1558 men and women aged 25 to 64 years, plasma fibrinogen, tPA activity and plasminogen activator inhibitor-I (PAI) activity were determined using specific assays. Associations with body mass index (BMI), waist-hip ratio (WHR), serum lipids and blood pressure were calculated with uni- and multivariate models where age and smoking were also introduced. In men age, truncal obesity, short height and low HDL cholesterol independently predicted fibrinogen (R2 0.20) while in women obesity per se, total cholesterol, systolic blood pressure, smoking and age were predictors (R2 0.29). tPA activity was negatively associated with BMI and serum triglyceride levels and positively with age in both sexes. In men diastolic blood pressure (R2 0.22) and in women WHR further independently predicted low fibrinolytic activity. HDL was associated with greater fibrinolysis in women (R2 0.15). Relationships with PAI-1 activity were essentially the reverse of tPA but stronger. Prospective interventional studies are needed to answer the question of causality.

References (31)

  • W.B. Kannel et al.

    Fibrinogen and risk of cardiovascular disease

    JAMA

    (1987)
  • L. Wilhelmsen et al.

    Fibrinogen as a risk factor for stroke and myocardial infarction

    N Engl J Med

    (1984)
  • M. DeWood et al.

    Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction

    N Engl J Med

    (1980)
  • A. Hamsten et al.

    Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

    Lancet

    (1987)
  • J.H. Jansson et al.

    Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death

    Br Heart J

    (1991)
  • Cited by (0)

    View full text